Foundayo vs Wegovy pill side effects compared
We may earn a commission from some links on this page. How we make money.
Side-by-side: common side effects
| Side effect | Foundayo (ATTAIN trials) | Wegovy pill (OASIS trials)* |
|---|---|---|
| Nausea | ~35% | ~44% |
| Vomiting | ~24% | ~24% |
| Diarrhea | ~25% | ~30% |
| Constipation | ~24% | ~24% |
| Abdominal pain | ~14% | ~20% |
| Indigestion | ~13% | ~9% |
| Headache | ~9% | ~14% |
| Dizziness | ~4% | ~8% |
*Wegovy pill figures are drawn from injectable semaglutide FDA label data, since the tablet label doesn't provide a separate side-effect table. Foundayo figures are from its 17.2 mg trial dose. The drugs were not tested head-to-head, so this comparison is approximate. Source: SingleCare analysis citing FDA prescribing information.
Important caveats about these numbers
- The two drugs have never been compared in a head-to-head trial. These numbers come from separate studies with different designs, populations, and doses.
- A 2026 indirect comparison (Michalak et al., Obesity Medicine) found orforglipron had significantly higher odds of GI-related discontinuation vs. semaglutide 25 mg (OR 13.86; 95% CI, 2–96). The researchers flagged this should be "interpreted with caution" due to small event numbers.
- Side effects are typically worst during dose escalation (the first 3 months) and usually improve once you reach a stable dose.
Serious side effects (both drugs)
Both carry the same FDA boxed warning for thyroid C-cell tumors (based on animal data; relevance to humans is unknown). Both also carry warnings for:
- Pancreatitis
- Gallbladder disease (Wegovy pill: ~2.5% of patients; Foundayo: ~1%)
- Dehydration-related acute kidney injury
- Hypersensitivity reactions
- Pulmonary aspiration risk under general anesthesia (tell your surgical team you're on a GLP-1)
Severe GI reactions occurred in about 3% of Foundayo patients and about 2% of Wegovy pill patients in trials.
The practical tolerability difference: dosing rules
This is where the two pills diverge most in day-to-day life:
| Wegovy pill | Foundayo | |
|---|---|---|
| When to take it | Morning only | Any time |
| Food restriction | Empty stomach required | None — take with or without food |
| Water restriction | Max 4 oz plain water | None |
| Wait after dose | 30 minutes before eating or drinking | None |
| Other meds | Wait 30 min before other oral medications | No special timing |
If your mornings are rushed, you travel frequently, or you take other morning medications, Foundayo's flexibility may be a meaningful quality-of-life difference — independent of the GI side effect profile.
Who should ask about which pill
- If nausea is your biggest concern: both cause it; the percentages favor Foundayo slightly, but no head-to-head trial confirms this. Discuss with your prescriber.
- If morning routine flexibility matters: Foundayo's no-restrictions rule is a clear advantage.
- If you're on Medicare: both are covered by the GLP-1 Bridge at $50/month. See Medicare coverage details.
- If gallbladder disease is a concern: Wegovy pill had ~2.5% gallbladder events vs. ~1% for Foundayo in trials — a difference worth flagging with your doctor.
This page is for informational purposes only and doesn't replace a conversation with your prescriber. Only a licensed clinician can evaluate which medication fits your health history and risk profile.
FAQ
Does the Wegovy pill or Foundayo cause more nausea?
Trial data suggest the Wegovy pill may cause slightly more nausea (~44% vs ~35% for Foundayo), but the two drugs have never been compared head-to-head. Nausea is typically worst during dose escalation and improves over time.
Are Foundayo and Wegovy pill side effects the same?
Very similar. Both cause nausea, vomiting, diarrhea, constipation, and abdominal pain. The Wegovy pill may cause slightly more nausea and headache; Foundayo may cause slightly more indigestion. Serious risks (pancreatitis, gallbladder disease, thyroid warning) are shared by both.
Which GLP-1 pill is easier to tolerate — Foundayo or Wegovy?
No head-to-head trial has established which is easier to tolerate in terms of side effects. The clearest practical difference is dosing: Foundayo has no food or timing restrictions, while the Wegovy pill requires an empty stomach and a 30-minute wait every morning.
Is gallbladder disease a risk with GLP-1 pills?
Yes, with both drugs. In trials, gallbladder disease occurred in about 2.5% of Wegovy pill patients and about 1% of Foundayo patients. Both FDA labels include a warning for this risk.
